DNDi was founded in 2003 by Doctors Without Borders/Médecins Sans Frontières (MSF), the Institut Pasteur, the Kenya Medical Research Institute, the Oswaldo Cruz Foundation in Brazil, the Indian Council of Medical Research, the Malaysian Ministry of Health, and the World Health Organization's Special Program for Research and Training in Tropical Diseases.
In our 15-year history, DNDi has developed seven treatments for five deadly diseases - malaria, sleeping sickness, Chagas disease, leishmaniasis, and pediatric HIV.
DNDi has received numerous awards, including the Rockefeller Foundation's 2013 Next Century Innovators Award, the 2013 Carlos Slim Health Award for Outstanding Institution, the Bill & Melinda Gates Foundation's 2014 Innovative Fund Award, and the Drug Information Association's 2016 President's Award for Outstanding Contribution to Global Health.